BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 21, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 29, 2022
View Archived Issues
ProfoundBio presents novel ADCs for cancer treatment
Read More
University of California discloses new PRMT8 inhibitors
Read More
Vertex Pharmaceuticals patents CFTR potentiators
Read More
Dana-Farber Cancer Institute discloses new HER2 inhibitors
Read More
Merck & Co. presents DGAT-2 inhibitors
Read More
Idorsia Pharmaceuticals patents LGALS3 inhibitors
Read More
AC-0027875, a gamma-secretase modulator for the treatment of AD
Read More
To escape radiation, tumor cells reversibly damage their DNA
Read More
Discovery of pyrrolo-pyridine benzamide derivative with promising antitumor efficacy in vivo
Read More
Apramycin shows efficacy in models of Mycobacterium abscessus infections
Read More
Discovery of novel D4R antagonist with favorable in vivo PK profile
Read More
ProMIS reports potential therapeutic approaches for ALS and nominates lead candidate
Read More
Series A financing supports Kelonia's development of in vivo gene delivery technology
Read More
HanAll advances novel immuno-oncology antibodies HL-187/HL-186
Read More
Chimera Bioengineering advances preclinical testing of CAR-T therapy CBIO-007 for solid tumors
Read More
